TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Aclaris Therapeutics, Inc. (NASDAQ: ACRS) Investor Securities Class Action Lawsuit 07/30/2019

  • If you purchased shares of Aclaris Therapeutics, Inc. (NASDAQ: ACRS), you have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

January 24, 2020 - An amended complaint was filed. July 30, 2019 - An investor in shares of Aclaris Therapeutics, Inc. (NASDAQ: ACRS) filed a lawsuit in the U.S. District Court for the Southern District of New York over alleged violations of Federal Securities Laws by Aclaris Therapeutics, Inc. in connection with certain allegedly false and misleading statements made between May 8, 2...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: